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Abstract: A systematic review was conducted to assess the employment rate of people with 
schizophrenia. Additionally, information from the selected studies concerning factors associ-
ated with employment and health-related quality of life (HRQoL) was examined. Employment 
rates ranged from 4% to 50.4%. The studies differed considerably in design, patient settings, 
and methods of recruitment. The most frequently reported factors associated with employment 
were negative and cognitive symptoms, age of onset, and duration and course of the disease. 
Individual characteristics associated with unemployment were older age, lower education, and 
sex (female). Additionally, environmental factors, eg, the availability of welfare benefits and 
vocational support programs, seemed to play a role. Generally, being employed was positively 
associated with HRQoL. However, the causal direction of this association remained unclear, as 
studies on the bidirectional relationship between employment and HRQoL were lacking.
Keywords: health-related quality of life, employment, work, unemployment, mental illness, 
patient characteristics, environment
Introduction
On a patient level, employment plays a central role in providing financial income and 
nonfinancial gains, including social identity, social contacts and support, a means of 
structuring and occupying time, activity and involvement, and a sense of personal 
achievement.1 People with long-term mental illness, including schizophrenia, are sen-
sitive to the negative effects of unemployment, and experience barriers to work, due 
to stigma, prejudice, and discrimination.1 Apart from these individual disadvantages, 
unemployment in people with schizophrenia is economically costly from a societal 
point of view. The estimated total societal cost of schizophrenia was 6.7 billion pounds 
in England for the year 2004–2005.2 Half of these costs were due to unemployment, 
absence from work, and premature mortality, amounting to 3.4 billion pounds.
Studies reporting on employment in people with schizophrenia show diverging 
figures. However, generally employment rates are low. Marwaha and Johnson were the 
first authors to publish a review on schizophrenia and employment.3 They concluded 
that there is a wide variation in reported employment rates. Additionally, their study 
showed that employment is correlated with positive outcomes in social functioning, 
symptom levels, quality of life (QoL), and self-esteem, but a clear causal relationship 
was not demonstrated.3
Increasingly, treatment models have focused on the subject of employment in 
people with schizophrenia. These treatment models strive, among other goals, to 
increase the individual’s own subjective view of well-being and satisfaction with his 
or her life. This development is in line with the shift in mental health services from 
an emphasis on treatment focused on reducing symptoms, based on a narrow notion 
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of health and disease, to a more holistic approach that takes 
both well-being and functioning into consideration.4 How-
ever, for people with schizophrenia, there is still a lack of 
information on the subject of employment and associated 
health-related QoL (HRQoL).
A previous study has shown that being employed is 
associated with a markedly better HRQoL for people with 
schizophrenia.5 However, the relationship between being 
employed and HRQoL may be bidirectional. It is known that 
the type of employment plays a crucial role in the effect on 
HRQoL.5 For instance, having a voluntary job, in general, 
means a low income. This may result in relatively poor 
living conditions and inability to afford social activities. 
Consequently, this may lead to a diminished HRQoL.6,7 In 
addition, although intuitively being employed may lead to 
increased HRQoL, the converse reasoning is also defend-
able, that is, having a higher HRQoL indicates being hap-
pier, presumably resulting in better capacities to perform 
daily activities such as a (paid) job. So, there is still a need 
to further explore the association between employment and 
HRQoL in schizophrenia.
Firstly, this review assessed the prevalence of employ-
ment in people with schizophrenia. Next, we aimed to 
identify factors associated with being employed in this 
population. Lastly, we examined the interrelation between 
being employed and HRQoL that was assessed in the studies 
under review.
Methods
A literature search was conducted to identify the employment 
rate in people with schizophrenia. We applied a broad defini-
tion of employment as having any job, whether full-time or 
part-time, and whether competitive or supported employ-
ment. In addition, we screened the selected papers for factors 
associated with being employed and for the interrelationship 
between being employed and HRQoL.
Search strategy
A systematic literature search was performed in PubMed 
and PsychInfo, including studies from 2000 until July 1, 
2013, including information on employment in representa-
tive (groups of) adults diagnosed with schizophrenia. We 
applied a broad search strategy for identifying studies. Con-
sequently, no criteria concerning study design were applied. 
The search terms included the Medical Subject Headings 
(MeSH) terms and Field terms “schizophrenia”, “employ-
ment”, “unemployment”, “paid work”, and “work capacity” 
(Supplementary material). The Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) state-
ment was followed for the reporting of systematic reviews 
and meta-analyses.8
Selection strategy
The selection of the abstracts was independently performed 
by two researchers. Discrepancies concerning inclusion or 
exclusion of an abstract were resolved by discussing the 
eligibility criteria during plenary meetings. The selection 
criteria were:
 1. Studies published in 2000 or later
 2. Studies performed in Western countries, or in Japan or 
Hong Kong
 3. Studies explicitly including people diagnosed with 
schizophrenia
 4. Studies for which information on (un)employment or 
work was given in the Abstract
 5. Case studies, editorial letters, comments, or conference 
proceedings were excluded
 6. Studies reporting on vocational rehabilitation therapy 
and/or vocational support programs were excluded.
To determine the eligibility of the full-text articles, the 
same selection criteria were used. Additional exclusion 
criteria were:
 7. Duplication of source data (ie, studies using samples of 
other included studies were excluded)
 8. Unavailability of the full-text publication
 9. Studies including selective samples, eg, the homeless, 
the convicted, or convenience samples, were excluded
10. Studies including study samples with 100 participants.
First, we presented the prevalence rates of employment 
in people with schizophrenia, derived from the review. In 
order to systematically describe the factors associated with 
employment, a simplified framework was used based on the 
model of Wilson and Cleary,9 which integrates health aspects 
with functional status and HRQoL. The basic domains of 
functional status that are commonly measured are physi-
cal”, “social”, “role”, and “psychological functioning”.10 
We defined being employed (or unemployed) as part of the 
functional status. The symptoms are reflected in the disease 
characteristics of the disorder – these may reflect physical 
impairment as well as patients’ emotional or cognitive state. 
Schizophrenia can be described as a syndrome11,12 character-
ized by:
•	 Positive symptoms
•	 Negative symptoms
•	 Cognitive symptoms
•	 Affective symptoms.
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Symptoms of schizophrenia are generally described in 
terms of a positive and a negative dimension. The Positive 
and Negative Syndrome Scale (PANSS) is, among other 
instruments, applied for measuring the severity of positive 
and negative symptoms.13 Positive symptoms indicate the 
occurrence of delusions and hallucinations, while negative 
symptoms indicate lack of motivation, reduction in spontane-
ous speech, and social withdrawal. Additionally, there may 
be a cognitive dimension (difficulties in memory, attention, 
and executive functioning) and a dimension of affective 
dysregulation (depression and manic symptoms).
Additionally, the disorder can be described in terms of 
the age at onset of the disease, the treatment setting, and the 
duration and course of the disease in terms of remission.
Finally, the functional status may be affected by the co-
occurrence of substance and alcohol abuse. Substance abuse 
has been found to be substantially more prevalent among 
people with schizophrenia.14,15 However, prevalence rates 
of co-occurring dependence or abuse in people with schizo-
phrenia may vary between countries.16 Substance abuse may 
worsen the impact of schizophrenia, leading to heightened 
social adjustment problems.17
The adapted model takes into account that characteristics 
of the individual as well as “characteristics of the environ-
ment” might impact the experience of symptoms, functional 
status, and HRQoL, and their relationships. Examples of 
individual characteristics are age, sex, personality, and 
individual expectations. With regard to being employed, 
specifically, motivation and “work readiness” are examples 
of characteristics of the individual that are probably of 
importance in finding and maintaining a paid job. Examples 
of environmental characteristics are social and vocational 
support, and social security programs. Finally, stigma is 
also a factor known to diminish the HRQoL of people with 
schizophrenia, even after recovery of the person.18
Overall QoL is preferably measured with a generic prefer-
ence based instrument. In this way, the impact of a condition 
on HRQoL can be assessed in terms that are relevant to any 
individual.
Data extraction
Employment rates from the publications were indepen-
dently extracted by two researchers. Additional data that 
were collected were the design of the study, the country, 
the sample size, exclusion criteria, the study setting, 
demographic information of the study population, clinical 
measures (eg, PANSS), length of illness, and comorbid-
ity. Additionally, findings concerning associations with 
employment and concerning employment and HRQoL 
were recorded.
Results
A total of 789 records were derived from the databases. After 
removal of duplicates, 701 abstracts were screened. In the 
search, six review studies were identified. Studies cited in 
these reviews that were not identified in our search and that 
met our selection criteria were added (Figure 1).
In total, 43 studies were eligible for analyzing the preva-
lence of employment (Table 1).
employment rate
Employment rates ranged from 4% to 50.4%.36,52 Generally, 
employment rates reported in the studies were based on 
different definitions of employment, eg, the employment in 
some studies was limited to competitive employment, while 
in other studies, respondents with supported or sheltered 
employment were counted too, and in a number of studies, 
students and/or housewives and those who had volunteer 
work were also counted as being employed. Additionally, 
in a number of studies, the definitions of employment that 
were applied were not reported. Five studies reported only 
unemployment figures. The studies differed considerably 
in design, patient settings, and methods of recruitment. 
Information on the time frame that was used for measur-
ing employment was generally lacking. In the majority of 
studies, no distinction was made between respondents with 
schizophrenia, and schizophreniform or schizoaffective dis-
orders. In addition, respondents may have been diagnosed on 
the basis of different criteria. This fragmented information 
limited a direct comparison of employment rates reported 
in these studies. Consequently, these results did not allow 
performance of a meta-analysis for estimating an average 
employment rate among people with schizophrenia.
Factors associated with employment
Disease characteristics
Positive symptoms
Marwaha et al41 examined employment status change during 
a 2-year European naturalistic study of people with schizo-
phrenia. The researchers found that more positive psychotic 
symptoms were predictive of job loss.
Negative symptoms
Our review included three studies that reported on associations 
of negative symptoms and employment. Üçok et al55 reported 
significantly higher PANSS negative symptoms scores in 
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unemployed respondents in comparison with employed 
respondents. In addition, regression analyses showed that the 
PANSS negative symptoms score was an independent predic-
tor of unemployment. Bobes et al23 found that presence of poor 
rapport and social withdrawal (items of negative PANSS) 
increased the risk of unemployment. Marwaha et al41 found 
that besides characteristics of the onset and duration of the 
disorder, more severe negative symptoms (PANSS subscale) 
were significantly negatively associated with the chance of 
getting work during a 2-year follow-up study.
Cognitive symptoms
Associations of cognitive symptoms and employment were 
reported in three studies in our review. Giugiario et al30 
reported significantly higher scores of verbal memory and 
more awareness of illness in respondents with competitive 
employment in comparison with unemployed subjects. In a 
longitudinal study, Holthausen et al35 found more problems of 
vocational functioning and significant lower chances of com-
petitive employment in persons with cognitive deficits. Hofer 
et al34 found that poorer cognitive scores were associated with 
a reduced probability of competitive employment.
Treatment setting
Another, more indirect indicator of disease severity may be 
the setting in which people receive care, ie, in- or outpatient 
care. Most studies included both in- and outpatient treated 
people. A number of studies did not provide information 
Records identified through 
database searching  (n=789)
PubMed: n=643
Additional records identified
through other sources
(n=0)
Records after duplicates removed
(n=701)
Records excluded, with reasons (n=524)
Reason 2 (n=31)
Reason 3 (n=181)
Reason 4 (n=269)
Reason 5 (n=23)
Reason 6 (n=20)
Records screened
(n=701)
Full-text articles assessed
for eligibility
(n=177) Reason 3 (n=11)
Reason 4 (n=58)
Reason 5 (n=5)
Reason 7 (n=14)
Reason 8 (n=17)
Reason 9 (n=13)
Reason 10 (n=16)
Full-text articles excluded, with 
reasons (n=134)
Studies included
(n=43)
Figure 1 Flow chart of the literature search.
Notes: Reasons for exclusion: 2= not performed in a western country or Japan or Hong Kong; 3= people with schizophrenia not explicitly included; 4= no (un)employment 
rate described; 5= case study; 6= study on vocational rehabilitation therapy or vocational support programs; 7= duplicate sources; 8= full text publication unavailable; 
9= studies including selective samples or convenience samples were excluded; 10= study sample had 100 subjects.
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employment and quality of life in schizophrenia
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on the treatment setting. Ten studies included only persons 
treated in an outpatient setting. Employment rates varied 
considerably, from 9.5% to 42.6%. No study was found exclu-
sively focusing on inpatients. Only in the study of Ye et al61 
were figures of employment rates for in- and outpatients sepa-
rately presented. Both the baseline and follow-up employment 
rates in persons treated as outpatients were almost four times 
higher in comparison with the rates among inpatients.
Age at onset, course, and duration
Marwaha et al examined predictors of being employed during 
a 2-year follow-up, using cross-national data derived from 
Germany, France, and the UK.41 Later age of illness onset, 
longer duration of illness, and a continuous illness course 
were negatively associated with the chance of getting work. 
Üçok et al reported significantly higher remission rates among 
employed subjects in comparison with unemployed subjects, 
and longer duration of remission contributed positively to 
employment status.55 Fourteen studies in our review reported 
on the duration of the illness.20,21,23,24,30,34,36,37,42,44,46,52,56,61 
A comparison of the employment rates and the duration of 
the disorder between these studies did not show a consistent 
pattern of declining rates with longer duration of the disorder. 
For example, McCreadie44 reported an employment rate of 
8% in study participants, with an average duration of 8 years, 
while Middelboe et al46 reported an employment rate of 12% 
in participants, with an average duration of 15 years.
Alcohol and substance abuse
In the study of Marwaha et al harmful use of alcohol at base-
line was a significant predictor of job loss during a 2-year 
follow up.41 In our review, 22 studies included information 
about the proportion of respondents with alcohol or substance 
abuse. The study of Xie et al60 included only patients with 
co-occurring substance abuse. The employment rate was 
6% at baseline and increased to 24% at 3-year follow up. 
In three studies, respondents with alcohol/substance abuse 
were excluded.34,47,52 Employment rates reported in these 
studies were 43.1% (1-year follow up), 27.8% (baseline), 
and 23.3% (1-year follow up), respectively. The figures 
presented in these studies are difficult to interpret given 
the different definitions of employment in these studies. In 
addition, in the study of Spellmann et al52 no definition of 
employment was stated.
Characteristics of the individual
Marwaha and Johnson3 reported on a number of demo-
graphic factors related to being employed in people with 
schizophrenia in their review, eg, sex, and marital and 
accommodation status. However, the authors reported that 
these associations were not consistently replicated between 
different studies. Among the studies in our review, Üçok et 
al55 found that younger age, more education, and sex (male) 
were independent positive predictors of employment. Hofer 
et al34 found that premorbid school functioning was positively 
correlated with competitive employment, and older age was 
found to be a significant negative predictor of employment.
Characteristics of the environment
Studies that examined environmental factors and the subject 
of employment were limited.
Marwaha et al42 conducted a study to compare employ-
ment patterns and associated environmental factors between 
and within three European countries: UK, France, and 
Germany. Variation in employment rate was found both 
between countries and between regional sites. The greatest 
variation was found on the national level, between centers 
rather than between countries. The authors suggested that 
social and vocational service factors within and between 
countries may contribute to this variation. One of these fac-
tors may be the availability of vocational services and place-
ments, as was seen in Germany. In two other studies that were 
performed in Germany, relatively high employment rates 
were reported.39,52 The low employment rate among people 
with schizophrenia in the UK reported by Marwaha et al42 
and Thornicroft et al53 was not confirmed by the study by 
Rosen and Garety.50 In the latter study, an employment rate 
of 41.2% (excluding 12% students) was reported.
In the study of Thornicroft et al53 including patients 
from five different European countries, relatively higher 
employment rates were found in southern countries (Spain 
and Italy) in comparison with Denmark and the Netherlands. 
The authors suggested that differences may be associated 
with differences in the availability of welfare benefits. 
Comparative low employment rates (12% in outpatients) 
in Scandinavian countries were also reported by Middelboe 
et al.46 In line with these findings, Giugiario et al30 reported 
a competitive employment rate of 30% in people with 
schizophrenia treated in an outpatient setting in Italy. Com-
parable figures were reported for outpatients in Spain (25.9% 
respectively 27.2%).23,56 Two studies were performed in 
Turkey.37,57 In the study of Karadayi et al37 employment was 
37.3%. However, the employment rate, including students, 
reported by Uzun et al57 was substantially lower (13.8%). 
This may partly be explained by the relatively older sample 
of the study population (median age 59 years).
 
N
eu
ro
ps
yc
hi
at
ric
 D
ise
as
e 
an
d 
Tr
ea
tm
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
5.
5.
87
.2
33
 o
n 
31
-J
an
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Neuropsychiatric Disease and Treatment 2015:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2137
employment and quality of life in schizophrenia
HRQoL 
In total, 12 studies were found that investigated the HRQoL 
of people with schizophrenia. Eight studies20,24,25,53,62–65 used 
a disease-specific HRQoL instrument: the Subjective Quality 
of Life (S-QoL) (one study), Heinrichs–Carpenter Quality of 
Life (QoL) scale (three studies), Lancaster Quality of Life 
Profile (two studies), and Lehman’s Quality of Life Inter-
view (QOLI) (two studies). Just one of the studies a generic 
HRQoL instrument was applied the Wisconsin Quality 
of Life Index (W-QLI) scale,25 and two studies applied a 
generic preference-based instrument (EQ-5D™ and Quality 
of Wellbeing).20,64 In nine of the 12 studies, the relationship 
between employment and HRQoL was studied (Table 2). All 
but one of the studies found a positive relationship between 
being employed and HRQoL. In the study by Xie et al60 which 
applied Lehman’s QOLI instrument, a nearly significant 
relationship (P=0.05) was established.
Discussion
Our review study showed that employment rates in people 
with schizophrenia vary between 4.5% and over 50%. There 
were significant differences between the definitions of 
employment that were applied in the studies. Nevertheless, 
unemployment figures are even more difficult to interpret, 
since these rates may refer to only those looking for work, 
while other rates may include respondents with long-term 
disability benefits or pensions. The comparison of employ-
ment rates between studies is further limited by differences in 
study designs, recruitment methods, diagnostic instruments, 
clinical variables reported, and different time frames for 
measuring employment. However, generally, employment in 
people with schizophrenia is relatively low, as was reported 
in the study of Marwaha et al.42 In that study, employment 
rates were presented for people with schizophrenia in the 
UK (12.9%), France (11.5%), and Germany (30.2%) in com-
parison with employment rates in the general population of 
these countries (of 71.0%, 62.2%, and 65.4%, respectively). 
Due to the methodological differences between the studies, 
we were unable to make a valid estimation of an average 
employment rate.
In addition to employment rates, we screened the 
papers on factors associated with employment, including 
the association of employment and HRQoL. The most fre-
quently reported disease characteristics that were negatively 
associated with employment were negative symptoms and 
cognitive symptoms. This is in line with the earlier findings 
reported by of Marwaha and Johnson.3 Additionally, later 
age of disease onset, and the duration and continuous course 
of the disease may play a role in employment status of the 
person. Finally, employment rates were higher in people 
treated in an outpatient setting in comparison with rates 
among inpatients. It is not clear to what extent this finding 
is related to the severity of the disease. Both individual 
and environmental characteristics were found to be associ-
ated with employment rates. Individual characteristics associ-
ated with unemployment were (older) age, lower education, 
and sex (females). Additionally, employment rates were 
associated with a number of environmental factors. The 
large variation of employment rates between countries or 
regions seem to indicate that environmental characteristics, 
such as the availability of welfare benefits and the avail-
ability of vocational services and sheltered employment, 
may play an important role. Employment rates seem to be 
lower in countries with an increased level of social security, 
as was reported in the study of Thornicroft et al.53 Relatively 
higher employment rates were generally found in studies 
performed in southern European countries. It can be assumed 
that these higher rates may be associated with dependence 
on the financial support of family members. These findings 
are in line with the study of Kilian and Becker, of the mac-
roeconomic indicators of labor force participation of people 
with schizophrenia.66 In addition, they found a close relation 
between general employment rates and employment rates 
of people with schizophrenia. In another study, a negative 
association was found between competitive employment 
and receipt of disability payment. Van der Wel et al reports 
that studies on the association of nonemployment among 
people with limiting longstanding illness and differences in 
welfare policies show equivocal results.67 More research is 
recommended for assessing associations of welfare policy 
and employment in patients with severe mental illness.
Several studies suggested that the availability of voca-
tional service factors may contribute to employment in 
people with schizophrenia. Increased access to rehabilitation 
services was associated with participation in both competitive 
and noncompetitive employment.65
Generally, being employed and HRQoL were positively 
associated. A possible explanation for the association 
between being employed and HRQoL that was found in our 
review was indicated by Brekke et al68 who described self-
esteem to be a mediating factor between being employed and 
HRQoL. A larger social network due to being employed, 
resulting in a better HRQoL, is being proposed as another 
potential explanation.25 Most studies applied a disease-
specific HRQoL instrument. This seems in line with the 
current discussion about the validity of preference-based QoL 
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instruments in people with schizophrenia. It is argued that 
generic preference-based instruments may not be appropriate 
for use in people with schizophrenia.69
The conceptual model of Wilson and Cleary was a 
helpful tool to describe the different factors associated with 
employment and HRQoL.9 The model has been widely 
applied to different patient populations.9 In the current review 
we found studies that reported on associations between dis-
ease characteristics, individual characteristics and environ-
mental characteristics and employment. Another important 
question relates to the association between employment 
and HRQol. That is, while employment may increase QoL, 
it is likely that those with higher QoL are more likely to 
be employed. Currently, there is little literature adequately 
assessing the causal relationship between these two domains, 
leading to a methodological gap in the literature. A limitation 
of our study is that we focused our literature search primarily 
on employment rates rather than on factors associated with 
employment. Consequently, we did not perform separate 
searches for factors associated with employment. However, 
due to the broad approach that was applied for reviewing the 
literature, the number of missing studies is assumed to be 
limited. Finally, we excluded studies on Individual Placement 
and Support and other vocational support programs, as our 
primary goal was to assess the general employment rate in 
people with schizophrenia. Supported employment programs 
are evidence-based practices to enhance people with mental 
health disability to return to work. Employment rates of per-
sons with schizophrenia included in supported employment 
trials may differ due to specific in- and exclusion criteria.
In conclusion, our review showed a great variation in 
employment rates in people with schizophrenia. However, 
the overall employment rate was low. Employment rates 
varied widely across and within countries. Generally, there 
was a positive association between being employed and 
HRQoL. Importantly, however, the causal direction of this 
association remained unclear. When aiming to improve 
employment participation and associated HRQoL among 
people diagnosed with schizophrenia, symptoms, functional 
status, demographic characteristics of the population, and 
environmental factors should be taken into account. A better 
understanding of the interrelations of these components could 
lead to more integrated and personalized health management, 
and outcome optimization, for people with schizophrenia. 
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